At Weave, we’re expanding what’s possible for regulatory teams—bringing AI and human expertise together to make drug development faster, more accurate, and more connected than ever. With $20M in new Series A funding, we’re scaling our AI-native platform to support the full regulatory lifecycle—from IND to NDA, BLA, and beyond—and empowering global teams to bring therapies to patients with greater confidence.

In this third edition of The Loom, we share what’s next for Weave—from platform enhancements that make regulatory work smarter and more seamless, to groundbreaking partnerships and research that showcase the real-world impact of human + AI collaboration.

What’s Inside This Edition

$20M Series A to Power What’s Next – Learn how our latest investment will accelerate platform development and expand Weave’s reach into global regulatory markets.

Smarter, Faster Regulatory Workflows – Discover new capabilities like AutoUpdate and Automatic Data Verification that keep teams inspection-ready and reduce manual review cycles.

Partner Spotlight: Weave x Parexel – See how our partnership with one of the world’s leading CROs is redefining early regulatory authoring and submission preparation.

Human + AI in Action – Explore findings from our study with Takeda on how AI-driven authoring can cut drafting time by 97% while maintaining high-quality outcomes.

Weaver Community – Meet our newest team members, explore open roles, and see where to find us at upcoming industry events.

We’re building the future of regulatory submissions—one workflow, one partnership, one innovation at a time. Don’t miss this issue.

At Weave, we’re transforming how regulatory teams prepare and manage submissions—infusing AI into every step to shorten timelines, reduce manual effort, and make end-to-end workflows smarter and more intuitive. With AutoCT now supporting clinical-phase submissions, the Weave platform continues to grow into a unified home for your regulatory lifecycle. In this second issue of The Loom, we highlight our latest capabilities and share a look at where we’re headed.

What’s Inside This Edition?

Drug Development Is a Continuum – Our CPO Brandon Rice reflects on the journey from AutoIND to AutoCT and how Weave is now supporting end-to-end submission needs across clinical programs.
New Platform Enhancements – Explore updates to the Data Room and new AI Templates that make drafting, organizing, and iterating content faster and more flexible than ever.
Prompting That Works – A four-part framework from Co-founder Umut Eser on how to write better AI prompts—plus high-impact tips that help teams get better results.
Weaver Spotlight – Meet Julie Xu, Senior Product Manager, and learn how she’s helping shape the future of AI-enabled health authority responses at Weave.

We’re building the future of regulatory submissions—one workflow, one innovation, one quarter at a time. Don’t miss this edition.

At Weave, we’re redefining regulatory submissions—leveraging AI to eliminate bottlenecks, reduce manual effort, and accelerate timelines. As we expand our platform and capabilities, Weave is now the single home for regulatory submissions. In this inaugural issue of The Loom, we share updates on our latest innovations and what’s next for Weave.

What’s Inside This Edition?

• The Future of Regulatory Submissions at Weave – 2024 was a breakthrough year—we launched AutoIND, helped generate our first INDs, and proved that AI can transform submission preparation. Now, we’re expanding beyond INDs to support clinical-phase filings, NDAs, and BLAs.
• New AutoIND Features – Explore enhancements in data exploration, automated hyperlinking, and content generation.
• Introducing AutoCT – A first glance at Weave’s next evolution in AI-powered submission automation.
• Be Part of the Future – Learn about our Design Partnership and help shape our expanded regulatory lifecycle support.
• Employee Spotlight – Get to know the Weave team (aka Weavers), their backgrounds, and the roles they play in transforming regulatory workflows
• Upcoming Events – Find out where Weave will be next and how to connect with our team.

We’re redefining regulatory submissions—don’t miss out on the latest advancements.